Clicky

Health

Moderna Reviews Clinical Trial Programs Across Portfolio at 2022 R&D Day

1200 277 Lauren

Interim data from Phase 1/2 propionic acidemia (PA) multi-dose Paramount trial shows mRNA-3927 was well-tolerated to date, with encouraging early signs of potential for clinical benefit Interim data from Phase 1/2 glycogen storage disease 1a…

EMA Committee for Medicinal Products for Human Use (CHMP) Adopts Positive Opinion Recommending Authorization for the Use of Moderna’s Omicron-Targeting Bivalent Booster in the European Union

1200 277 Riley

CAMBRIDGE, MA / ACCESSWIRE / September 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human…

Moderna to Host R&D Day on Thursday, September 8, 2022

1200 277 Lauren

CAMBRIDGE, MA / ACCESSWIRE / August 29, 2022 / Moderna, Inc. (Nasdaq:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it will host its in-person and virtual R&D Day at 9:00 a.m.…

Empower Clinics Maintains Strong Volume for Its COVID-19 Testing Solutions in Vancouver

270 50 Rick

VANCOUVER, BC / ACCESSWIRE / August 5, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) (“Empower” or the “Company“) an integrated healthcare company – serving patients through medical centers, telemedicine platforms, a medical device company, and a high…

Health Canada Authorizes Moderna’s COVID-19 Vaccine in Young Children (6 Months-5 Years)

1200 277 Rick

CAMBRIDGE, MA / ACCESSWIRE / July 14, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that Health Canada has approved the use of Moderna’s mRNA COVID-19 vaccine,…

International Meeting of Catholic Scholars and Lawyers on COVID-19 Measures Wraps up in Rome: Aquinas, Law & Politics in Times of COVID: 24-25 June 2022

150 150 Jessi

ROME, ITALY / ACCESSWIRE / June 29, 2022 / After two years of COVID-19 policies, an International group of Catholic scholars and lawyers gathered under the auspices of the International Catholic Jurists Forum (ICJF) to study the theme…

Net Medical Adds Mobile on-site CLIA Labs in Response to Growth in Number of People Testing Positive for COVID

624 108 admin

ALBUQUERQUE, NM / ACCESSWIRE / June 14, 2022 / Net Medical (OTC Pink:NMXS) said today it is upgrading and increasing its fleet of mobile testing labs in response to previously reported growth in positive tests for…

Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron

1200 277 Rick

Data Show Significantly Higher Geometric Mean Titer Ratios, Meeting Prespecified Endpoints for Superiority Against Omicron Variant mRNA-1273.214 Exhibited an 8-Fold Boost in Neutralizing Geometric Mean Titers Against Omicron Among Baseline Seronegative Participants Safety and Tolerability…

Moderna to Present at Upcoming Conferences in June 2022

1200 277 Lauren

CAMBRIDGE, MA / ACCESSWIRE / June 1, 2022 / Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced its participation in the following upcoming investor conferences: 2022 Jefferies Healthcare Conference…